Healthcare Industry News CSR News

"We Have a Health Disparities Problem in America": Meet a Woman on a Mission to Improve Healthcare for Black Women

Summary: 

The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.

Article

The U.S. has one of the highest maternal mortality rates in the developed world, with women of color especially at risk. Dr. Robyn R. Jones, Senior Medical Director at Johnson & Johnson, is determined to change that and find ways to address this urgent crisis.

4 Latest Facts About Johnson & Johnson's Investigational COVID-19 Vaccine

Summary: 

A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.

Blog

A preclinical study just published in Nature shows that the company's investigational vaccine has shown positive early data for eliciting an immune response against SARS-CoV-2, the virus that causes COVID-19. We share more about the findings from the recent preclinical study, along with other up-to-date information about the potential vaccine candidate.

The Role of Design, Test & Security in Today's Healthcare Advancements

By Michele Robinson-Pontbriand | Director Corporate Social Responsibility
Blog

Technology has always played a critical role in the healthcare industry. However, recent advancements are driving a revolution in capabilities and opportunities to improve the health and wellness of people around the world. And at a time when such advancements are sorely needed, I might add.

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

Addressing COVID-19 in Vulnerable Diamond and Gold Mining Communities

Mobilizing the Central African Republic mining community to combat the impacts of COVID-19
Blog

This piece was written by Terah DeJong, technical deputy for the U.S. Agency for International Development (USAID) Artisanal Mining and Property Rights (AMPR) project, implemented by Tetra Tech.

This post originally ran on LandLinks.

“I Was Working on a Potential COVID-19 Vaccine—Then My Wife Got Sick”: Meet a Researcher Whose Personal Experience Is Fueling His Fight Against the Pandemic

Within a matter of weeks, Ramon Polo's work and home life were completely changed by the novel coronavirus—and he's a stronger scientist and husband for it.
Blog

In late January—weeks before many people had even heard of the novel coronavirus—Ramon Polo, PharmD, Ph.D., started to work on finding solutions to fight the virus, which data suggested had the potential to become a global pandemic.

As the Vice President of Regulatory Affairs for Infectious Diseases and Vaccines and Global Public Health at Johnson & Johnson, Dr. Polo quickly began to focus on working with healthcare authorities across the globe to collaborate on the development of both therapeutic treatments and a potential vaccine for the rapidly spreading novel coronavirus.

The Road to a Vaccine, Season 2, Ep. 2: How New COVID-19 Outbreaks Are Impacting a Global Return to Normal

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In Episode 2, Lisa Ling talks with Dr. Francis Collins, Director, NIH about the latest on treatments and vaccines. Also, Harvard's Dr. Ashish Jha shares how the virus affects the body and Johns Hopkins' Dr. Tom Inglesby explains what the new data on spread means for people.

The Road to a Vaccine, Season 2, Ep. 1: How Lessons Learned in Fighting HIV Help Us Battle COVID-19

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In the Season 2 premiere, Lisa Ling checks into the AIDS 2020 conference to talk with HIV advocate Laverne Cox and Johnson &. Johnson Chief Scientific Officer Paul Stoffels, M.D., about how HIV vaccine research is informing work on COVID-19 vaccines.

Medtronic: Leadership During the COVID-19 Crisis

Medtronic CEO talks with TriplePundit about delivering on our Mission during a pandemic
Article

CEO Geoff Martha was recently interviewed by TriplePundit about the company's response to COVID-19. Watch clips of the conversation, where he discusses how our Mission guided him and empowered us to put purpose over profit in a time of crisis.

Watch clips here.

Medtronic: Remotely, Together

Though we are separated by distance, the world is coming together to fight coronavirus
Article

Coronavirus reminds us how our economies, industries, rituals, and life as we know it, exist in a delicate balance. What happens in one corner of the world inevitably impacts another. And seemingly overnight, those connections start to unravel. So while we continue to search for answers, we must find ways to help put things back together.

Pages

Subscribe to Healthcare Industry News